tiprankstipranks

William Schwieterman Insider Profile

4 Followers
William Schwieterman, President & CEO, Director at Oncotelic Therapeutics, holds 625.75K shares in Oncotelic Therapeutics (Ticker: OTLC), holds 0.00 shares in Chelsea Therapeutics (Ticker: CHTP).
tipranks
William Schwieterman

William Schwieterman
Oncotelic Therapeutics (OTLC)
President & CEO, Director

Not Ranked
William Schwieterman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$24K
100.00%
A breakdown of William Schwieterman's holdings

Insider Roles

Oncotelic Therapeutics
(OTLC)
President & CEO, Director
Roles that William Schwieterman holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by William Schwieterman

William Schwieterman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncotelic Therapeutics
Apr 16, 2018
President & CEO, Director
Uninformative Buy
$24.40K
CHTP
Chelsea Therapeutics
Jun 25, 2014
Uninformative Sell
List of latest transactions for each holding click on a transaction to see William Schwieterman's performance on stock

William Schwieterman insider profile FAQ

What is the percentage of profitable transactions made by William Schwieterman?
The percentage of profitable transactions made by William Schwieterman is ―.
    What is the average return per transaction made by William Schwieterman?
    The average return per transaction made by William Schwieterman is ―.
      What stocks does William Schwieterman hold?
      William Schwieterman holds: OTLC, CHTP stocks.
        What was William Schwieterman’s latest transaction?
        William Schwieterman latest transaction was an Uninformative Buy of ―.
          What was William Schwieterman's most profitable transaction?
          William Schwieterman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is William Schwieterman's role in Oncotelic Therapeutics?
            William Schwieterman's role in Oncotelic Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.